Table IV.
Oral cavity | I–III including IIb |
Oropharynx | I–III including IIb; recognise significant chance of contralateral disease |
Supraglottis | IIa–III; IIb and IV can be spared. Contralateral SND not indicated for lateralised tumours |
Glottis | IIa–III; IIb can be spared. Include IV for T3 and T4 primaries |
Subgottis | II–IV, VI |
Hypopharynx | II–IV |